Concepedia

Publication | Closed Access

Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder

DOI

57

Citations

28

References

2016

Year

Svetlana Hakobyan, Sebastian Luppe, David Evans, Katharine Harding, Samantha Loveless, Neil P. Robertson, B. Paul Morgan
Multiple Sclerosis Journal

Abstract

NMOSD is distinguished from MS by plasma complement biomarkers. Selected complement analytes enable differential diagnosis. Findings support trials of anti-complement therapies in NMOSD.

References

YearCitations

Page 1